A detailed history of Pictet Asset Management Sa transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Pictet Asset Management Sa holds 113,721 shares of LGND stock, worth $12.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
113,721
Previous 89,867 26.54%
Holding current value
$12.9 Million
Previous $6.61 Million 24.04%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

BUY
$69.53 - $79.33 $1.66 Million - $1.89 Million
23,854 Added 26.54%
113,721 $8.2 Million
Q1 2023

May 10, 2023

BUY
$65.67 - $77.08 $5.9 Million - $6.93 Million
89,867 New
89,867 $6.61 Million

Others Institutions Holding LGND

About LIGAND PHARMACEUTICALS INC


  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.91B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Pictet Asset Management Sa Portfolio

Follow Pictet Asset Management Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Sa with notifications on news.